This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dodoo, D.
Right arrow Articles by Hviid, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dodoo, D.
Right arrow Articles by Hviid, L.

 Previous Article  |  Next Article 

Infection and Immunity, May 1999, p. 2131-2137, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Levels of Antibody to Conserved Parts of Plasmodium falciparum Merozoite Surface Protein 1 in Ghanaian Children Are Not Associated with Protection from Clinical Malaria

Daniel Dodoo,1,2,* Thor G. Theander,2 Jorgen A. L. Kurtzhals,1,2 Kojo Koram,1 Eleanor Riley,3 Bartholomew D. Akanmori,1 Francis K. Nkrumah,1 and Lars Hviid2

Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana1; Centre for Medical Parasitology, Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), and Institute of Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark2; and Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom3

Received 11 December 1998/Returned for modification 21 January 1999/Accepted 12 February 1999

The 19-kDa conserved C-terminal part of the Plasmodium falciparum merozoite surface protein 1 (PfMSP119) is a malaria vaccine candidate antigen, and human antibody responses to PfMSP119 have been associated with protection against clinical malaria. In this longitudinal study carried out in an area of stable but seasonal malaria transmission with an estimated parasite inoculation of about 20 infective bites/year, we monitored 266 3- to 15-year-old Ghanaian children clinically and parasitologically over a period of 18 months. Blood samples were collected at the beginning of the study before the major malaria season in April and after the season in November. Using enzyme-linked immunosorbent assay, we measured antibody responses to recombinant gluthathione S-transferase-PfMSP119 fusion proteins corresponding to the Wellcome and MAD20 allelic variants in these samples. Prevalence of antibodies recognizing the Wellcome 19 construct containing both epidermal growth factor (EGF)-like motifs in Wellcome type PfMSP119 was about 30%. Prevalence of antibodies to constructs containing only the first EGF domain from either Wellcome or MAD20 type PfMSP119 was about 15%, whereas antibodies recognizing a construct containing only the second EGF domain of MAD20 type PfMSP119 was found in only about 4% of the donors. Neither the prevalence nor the levels of any of the antibody specificities varied significantly with season, age, or sex. Significantly, and in contrast to previous reports from other parts of West Africa, we found no evidence of an association between antibody responses to PfMSP119 and clinical protection against malaria.


* Corresponding author. Mailing address: Department of Infectious Diseases M7641, Rigshospitalet, Tagensvej 20, 2200 Copenhagen N, Denmark. Phone: 45 35 45 73 75. Fax: 45 35 45 76 44. E-mail: ddcmp{at}rh.dk.


Infection and Immunity, May 1999, p. 2131-2137, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Murhandarwati, E. E. H., Wang, L., Black, C. G., Nhan, D. H., Richie, T. L., Coppel, R. L. (2009). Inhibitory Antibodies Specific for the 19-Kilodalton Fragment of Merozoite Surface Protein 1 Do Not Correlate with Delayed Appearance of Infection with Plasmodium falciparum in Semi-Immune Individuals in Vietnam. Infect. Immun. 77: 4510-4517 [Abstract] [Full Text]  
  • Bejon, P., Warimwe, G., Mackintosh, C. L., Mackinnon, M. J., Kinyanjui, S. M., Musyoki, J. N., Bull, P. C., Marsh, K. (2009). Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure. Infect. Immun. 77: 1917-1923 [Abstract] [Full Text]  
  • Stanisic, D. I., Richards, J. S., McCallum, F. J., Michon, P., King, C. L., Schoepflin, S., Gilson, P. R., Murphy, V. J., Anders, R. F., Mueller, I., Beeson, J. G. (2009). Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness. Infect. Immun. 77: 1165-1174 [Abstract] [Full Text]  
  • Arnot, D. E., Cavanagh, D. R., Remarque, E. J., Creasey, A. M., Sowa, M. P. K., Morgan, W. D., Holder, A. A., Longacre, S., Thomas, A. W. (2008). Comparative Testing of Six Antigen-Based Malaria Vaccine Candidates Directed Toward Merozoite-Stage Plasmodium falciparum. CVI 15: 1345-1355 [Abstract] [Full Text]  
  • Vestergaard, L. S., Lusingu, J. P., Nielsen, M. A., Mmbando, B. P., Dodoo, D., Akanmori, B. D., Alifrangis, M., Bygbjerg, I. C., Lemnge, M. M., Staalsoe, T., Hviid, L., Theander, T. G. (2008). Differences in Human Antibody Reactivity to Plasmodium falciparum Variant Surface Antigens Are Dependent on Age and Malaria Transmission Intensity in Northeastern Tanzania. Infect. Immun. 76: 2706-2714 [Abstract] [Full Text]  
  • Osier, F. H. A., Fegan, G., Polley, S. D., Murungi, L., Verra, F., Tetteh, K. K. A., Lowe, B., Mwangi, T., Bull, P. C., Thomas, A. W., Cavanagh, D. R., McBride, J. S., Lanar, D. E., Mackinnon, M. J., Conway, D. J., Marsh, K. (2008). Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria. Infect. Immun. 76: 2240-2248 [Abstract] [Full Text]  
  • Nebie, I., Diarra, A., Ouedraogo, A., Soulama, I., Bougouma, E. C., Tiono, A. B., Konate, A. T., Chilengi, R., Theisen, M., Dodoo, D., Remarque, E., Bosomprah, S., Milligan, P., Sirima, S. B. (2008). Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal Malaria Transmission in Burkina Faso, West Africa. Infect. Immun. 76: 759-766 [Abstract] [Full Text]  
  • Dent, A. E., Yohn, C. T., Zimmerman, P. A., Vulule, J., Kazura, J. W., Moormann, A. M. (2007). A Polymerase Chain Reaction/Ligase Detection Reaction Fluorescent Microsphere Assay to Determine Plasmodium falciparum MSP-119 Haplotypes. Am J Trop Med Hyg 77: 250-255 [Abstract] [Full Text]  
  • Nogueira, P. A., Piovesan Alves, F., Fernandez-Becerra, C., Pein, O., Rodrigues Santos, N., Pereira da Silva, L. H., Plessman Camargo, E., del Portillo, H. A. (2006). A Reduced Risk of Infection with Plasmodium vivax and Clinical Protection against Malaria Are Associated with Antibodies against the N Terminus but Not the C Terminus of Merozoite Surface Protein 1.. Infect. Immun. 74: 2726-2733 [Abstract] [Full Text]  
  • Lusingu, J. P. A., Jensen, A. T. R., Vestergaard, L. S., Minja, D. T., Dalgaard, M. B., Gesase, S., Mmbando, B. P., Kitua, A. Y., Lemnge, M. M., Cavanagh, D., Hviid, L., Theander, T. G. (2006). Levels of Plasma Immunoglobulin G with Specificity against the Cysteine-Rich Interdomain Regions of a Semiconserved Plasmodium falciparum Erythrocyte Membrane Protein 1, VAR4, Predict Protection against Malarial Anemia and Febrile Episodes.. Infect. Immun. 74: 2867-2875 [Abstract] [Full Text]  
  • Pinder, M., Sutherland, C. J., Sisay-Joof, F., Ismaili, J., McCall, M. B. B., Ord, R., Hallett, R., Holder, A. A., Milligan, P. (2006). Immunoglobulin G Antibodies to Merozoite Surface Antigens Are Associated with Recovery from Chloroquine-Resistant Plasmodium falciparum in Gambian Children.. Infect. Immun. 74: 2887-2893 [Abstract] [Full Text]  
  • Cavanagh, D. R., Dodoo, D., Hviid, L., Kurtzhals, J. A. L., Theander, T. G., Akanmori, B. D., Polley, S., Conway, D. J., Koram, K., McBride, J. S. (2004). Antibodies to the N-Terminal Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Associated with Protection against Clinical Malaria. Infect. Immun. 72: 6492-6502 [Abstract] [Full Text]  
  • Gatton, M. L., Cheng, Q. (2004). Modeling the Development of Acquired Clinical Immunity to Plasmodium falciparum Malaria. Infect. Immun. 72: 6538-6545 [Abstract] [Full Text]  
  • Corran, P. H., O'Donnell, R. A., Todd, J., Uthaipibull, C., Holder, A. A., Crabb, B. S., Riley, E. M. (2004). The Fine Specificity, but Not the Invasion Inhibitory Activity, of 19-Kilodalton Merozoite Surface Protein 1-Specific Antibodies Is Associated with Resistance to Malarial Parasitemia in a Cross-Sectional Survey in The Gambia. Infect. Immun. 72: 6185-6189 [Abstract] [Full Text]  
  • John, C. C., O'Donnell, R. A., Sumba, P. O., Moormann, A. M., de Koning-Ward, T. F., King, C. L., Kazura, J. W., Crabb, B. S. (2004). Evidence That Invasion-Inhibitory Antibodies Specific for the 19-kDa Fragment of Merozoite Surface Protein-1 (MSP-119) Can Play a Protective Role against Blood-Stage Plasmodium falciparum Infection in Individuals in a Malaria Endemic Area of Africa. J. Immunol. 173: 666-672 [Abstract] [Full Text]  
  • Jensen, A. T.R., Magistrado, P., Sharp, S., Joergensen, L., Lavstsen, T., Chiucchiuini, A., Salanti, A., Vestergaard, L. S., Lusingu, J. P., Hermsen, R., Sauerwein, R., Christensen, J., Nielsen, M. A., Hviid, L., Sutherland, C., Staalsoe, T., Theander, T. G. (2004). Plasmodium falciparum Associated with Severe Childhood Malaria Preferentially Expresses PfEMP1 Encoded by Group A var Genes. JEM 199: 1179-1190 [Abstract] [Full Text]  
  • Okech, B. A., Corran, P. H., Todd, J., Joynson-Hicks, A., Uthaipibull, C., Egwang, T. G., Holder, A. A., Riley, E. M. (2004). Fine Specificity of Serum Antibodies to Plasmodium falciparum Merozoite Surface Protein, PfMSP-119, Predicts Protection from Malaria Infection and High-Density Parasitemia. Infect. Immun. 72: 1557-1567 [Abstract] [Full Text]  
  • Soe, S., Theisen, M., Roussilhon, C., Aye, K.-S., Druilhe, P. (2004). Association between Protection against Clinical Malaria and Antibodies to Merozoite Surface Antigens in an Area of Hyperendemicity in Myanmar: Complementarity between Responses to Merozoite Surface Protein 3 and the 220-Kilodalton Glutamate-Rich Protein. Infect. Immun. 72: 247-252 [Abstract] [Full Text]  
  • Polley, S. D., Tetteh, K. K. A., Cavanagh, D. R., Pearce, R. J., Lloyd, J. M., Bojang, K. A., Okenu, D. M. N., Greenwood, B. M., McBride, J. S., Conway, D. J. (2003). Repeat Sequences in Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Targets of Antibodies Associated with Protection from Malaria. Infect. Immun. 71: 1833-1842 [Abstract] [Full Text]  
  • Kedzierski, L., Black, C. G., Goschnick, M. W., Stowers, A. W., Coppel, R. L. (2002). Immunization with a Combination of Merozoite Surface Proteins 4/5 and 1 Enhances Protection against Lethal Challenge with Plasmodium yoelii. Infect. Immun. 70: 6606-6613 [Abstract] [Full Text]  
  • Nwuba, R. I., Sodeinde, O., Anumudu, C. I., Omosun, Y. O., Odaibo, A. B., Holder, A. A., Nwagwu, M. (2002). The Human Immune Response to Plasmodium falciparum Includes Both Antibodies That Inhibit Merozoite Surface Protein 1 Secondary Processing and Blocking Antibodies. Infect. Immun. 70: 5328-5331 [Abstract] [Full Text]  
  • Ofori, M. F., Dodoo, D., Staalsoe, T., Kurtzhals, J. A. L., Koram, K., Theander, T. G., Akanmori, B. D., Hviid, L. (2002). Malaria-Induced Acquisition of Antibodies to Plasmodium falciparum Variant Surface Antigens. Infect. Immun. 70: 2982-2988 [Abstract] [Full Text]  
  • Ahlborg, N., Ling, I. T., Howard, W., Holder, A. A., Riley, E. M. (2002). Protective Immune Responses to the 42-Kilodalton (kDa) Region of Plasmodium yoelii Merozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa Region. Infect. Immun. 70: 820-825 [Abstract] [Full Text]  
  • Theisen, M., Dodoo, D., Toure-Balde, A., Soe, S., Corradin, G., Koram, K. K., Kurtzhals, J. A. L., Hviid, L., Theander, T., Akanmori, B., Ndiaye, M., Druilhe, P. (2001). Selection of Glutamate-Rich Protein Long Synthetic Peptides for Vaccine Development: Antigenicity and Relationship with Clinical Protection and Immunogenicity. Infect. Immun. 69: 5223-5229 [Abstract] [Full Text]  
  • Wang, L., Richie, T. L., Stowers, A., Nhan, D. H., Coppel, R. L. (2001). Naturally Acquired Antibody Responses to Plasmodium falciparum Merozoite Surface Protein 4 in a Population Living in an Area of Endemicity in Vietnam. Infect. Immun. 69: 4390-4397 [Abstract] [Full Text]  
  • Dodoo, D., Staalsoe, T., Giha, H., Kurtzhals, J. A. L., Akanmori, B. D., Koram, K., Dunyo, S., Nkrumah, F. K., Hviid, L., Theander, T. G. (2001). Antibodies to Variant Antigens on the Surfaces of Infected Erythrocytes Are Associated with Protection from Malaria in Ghanaian Children. Infect. Immun. 69: 3713-3718 [Abstract] [Full Text]  
  • Quin, S. J., Langhorne, J. (2001). Different Regions of the Malaria Merozoite Surface Protein 1 of Plasmodium chabaudi Elicit Distinct T-Cell and Antibody Isotype Responses. Infect. Immun. 69: 2245-2251 [Abstract] [Full Text]  
  • Cavanagh, D. R., Dobano, C., Elhassan, I. M., Marsh, K., Elhassan, A., Hviid, L., Khalil, E. A. T. G., Theander, T. G., Arnot, D. E., McBride, J. S. (2001). Differential Patterns of Human Immunoglobulin G Subclass Responses to Distinct Regions of a Single Protein, the Merozoite Surface Protein 1 of Plasmodium falciparum. Infect. Immun. 69: 1207-1211 [Abstract] [Full Text]  
  • Okenu, D. M. N., Riley, E. M., Bickle, Q. D., Agomo, P. U., Barbosa, A., Daugherty, J. R., Lanar, D. E., Conway, D. J. (2000). Analysis of Human Antibodies to Erythrocyte Binding Antigen 175 of Plasmodium falciparum. Infect. Immun. 68: 5559-5566 [Abstract] [Full Text]